Insurance

Updated:

REVIUM Rückversicherung

REVIUM Rückversicherung was founded in 2007 as a wholly owned subsidiary of B. Braun SE, the Melsungen-based medical technology group controlled by the Braun...

REVIUM Rückversicherung logo

REVIUM Rückversicherung

REVIUM Rückversicherung was founded in 2007 as a wholly owned subsidiary of B. Braun SE, the Melsungen-based medical technology group controlled by the Braun family since 1839. The parent company, led by sixth-generation CEO Anna Maria Braun, generated €9.4 billion in group sales in fiscal year 2025. Ludwig Georg Braun, Anna Maria's father and the long-time former CEO, now serves as Chairman of the Supervisory Board, overseeing the family's industrial and financial assets, which include reinsurance operations and board seats at Stihl AG, WIKUS-Sägenfabrik, and Wilhelm Werhahn KG. REVIUM manages a reinsurance portfolio that stems from premiums generated across the B. Braun Group's global healthcare operations. The firm directs that capital into a venture investment strategy that spans early-stage seed and start-up rounds through expansion and late-stage commitments. Unlike most corporate captives that outsource asset management, REVIUM executes a direct investment program from Melsungen, targeting companies that may align with or adjacent to the parent's core competency in medical technology. The firm's investment posture is generalist within venture, with no public disclosures limiting sector exposure. The firm's investment footprint remains rooted in Germany, with its sole office at B. Braun's headquarters on Carl-Braun-Straße in Melsungen. Ludwig Georg Braun's extensive network — built through his own leadership of B. Braun and supervisory roles at peer industrial groups — provides REVIUM with access to deal flow across the German Mittelstand and beyond. The B. Braun Group also maintains the B. Braun Stiftung, a philanthropic foundation structurally separate from the reinsurance operations, focused on healthcare advancement. REVIUM operates as a classic captive reinsurer embedded inside an industrial family office, creating a structural advantage rarely found in third-party insurance portfolios. The vehicle converts underwriting float from B. Braun's core business into a permanent capital base for venture investing, eliminating the fundraising cycle that constrains independent VCs. This architecture gives the investment team patience and flexibility, allowing it to hold positions across the entire lifecycle of a company — from seed to late-stage — without external LP pressure. The arrangement mirrors other German industrial-family captives that have quietly built substantial venture portfolios behind operating company balance sheets.

General information

Firm type

Insurance

Year founded

2007

Location

Region

Europe

Country

Germany

City

Melsungen

Corporate office

Melsungen, Germany

Principals

Ludwig Georg Braun

Chairman of the Supervisory Board

Anna Maria Braun

CEO of B. Braun SE

Sector focus

Healthcare ServicesMedical Devices

Frequently asked questions

Who runs investment decisions at REVIUM Rückversicherung?

Investment oversight sits with the supervisory board of parent B. Braun SE, chaired by Ludwig Georg Braun.

How is REVIUM Rückversicherung related to B. Braun SE?

REVIUM Rückversicherung AG is a 100 percent subsidiary of B. Braun SE.

Where does the underlying wealth come from?

The capital base originates from B. Braun SE, the medical technology group controlled by the Braun family.

Does REVIUM Rückversicherung maintain philanthropic structures?

Philanthropic activity is handled through the separate B. Braun Stiftung.

What is REVIUM Rückversicherung's known posture on external mandates?

The firm focuses on internal group risks and does not disclose third-party fund commitments or external GP relationships.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Melsungen Insurance profiles